# Multimodal Explainability & Decision Deconstruction Report
**Stage 04 Integration Subsystem**

> [!IMPORTANT]
> **MANDATORY SYNTHETIC DATA & REGULATORY DISCLAIMER**:
> *Synthetic research integration only. This system is not clinically validated and must not be interpreted as evidence of clinical efficacy, diagnostic performance, or treatment recommendation.*
> All upstream stages (01 ML, 02 DL, 03 NLP) and the integration layer operate strictly on synthetic oncology research records. This software is a decision-support research prototype and is NOT an approved medical device.


## 1. Attribution Architecture
For every evaluated patient, the integration subsystem provides:
- Relative numerical risk contribution of each active modality.
- Observed clinical evidence: extracted genomic mutations, co-prescribed medications, and adverse event profiles.
- Reasoning narrative explaining why the patient was assigned to their specific risk tier.
- Explicit non-prescriptive research wording.
